-
1
المؤلفون: Patrice Maboudou, Véronique Maguer-Satta, Bruno Quesnel, Quentin Fovez, Raeeka Khamari, William Laine, Jérôme Kluza, Sandrine Jeanpierre, Didier Bouscary, Béatrice Turcq, Philippe Marchetti, Salim Dekiouk, Anne Trinh, Marie Joncquel, Thierry Idziorek, Valérie Coiteux, Bart Ghesquière, Nicolas Germain, Francois-Xavier Mahon
المساهمون: Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 (CANTHER), Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Centre National de la Recherche Scientifique (CNRS), CHU Lille, Institut pour la recherche sur le cancer de Lille [Lille] (IRCL), Actions for OnCogenesis understanding and Target Identification in ONcology (ACTION), Institut Bergonié [Bordeaux], UNICANCER-UNICANCER-Université Bordeaux Segalen - Bordeaux 2-Institut National de la Santé et de la Recherche Médicale (INSERM), UNICANCER, Institut Cochin (IC UM3 (UMR 8104 / U1016)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven), This work received a financial support from INSERM, UNIVERSITE DE LILLE, Ligue contre le Cancer (to PM and JK), a special financial support from the Association pour l’Etude des Anomalies Congénitales Neurodev of Pr. B. Poupard (to PM). AT is a recipient of a CHRU Lille-Région Nord-Pas de Calais fellowship. RK and QF are recipients of a University of Lille fellowship., Dupuis, Christine, Centre National de la Recherche Scientifique (CNRS), Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER], Institut pour la recherche sur le cancer de Lille [Lille] [IRCL], Actions for OnCogenesis understanding and Target Identification in ONcology [ACTION], Institut Cochin [IC UM3 (UMR 8104 / U1016)], Centre Hospitalier Régional Universitaire [Lille] [CHRU Lille], Catholic University of Leuven - Katholieke Universiteit Leuven [KU Leuven]
المصدر: Molecular metabolism
Molecular metabolism, 2022, 55, pp.101410. ⟨10.1016/j.molmet.2021.101410⟩
Molecular Metabolism, Vol 55, Iss, Pp 101410-(2022)
Molecular Metabolismمصطلحات موضوعية: Synthetic lethality, [SDV]Life Sciences [q-bio], Cooperativity, Apoptosis, BCR-ABL1 (B Cell Receptor-Abelson), LSC (leukemic stem cell), L asparaginase, Mice, CML (chronic myeloid leukemia), TKI (tyrosine kinase inhibitors), Cell Line, Tumor, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, hemic and lymphatic diseases, LSC, Animals, Asparaginase, Humans, Metabolic addiction, Stem-like cells, Molecular Biology, Protein Kinase Inhibitors, Internal medicine, Metabolic stress, Cell Proliferation, Chemistry, stem-like cells, Cell Biology, Protein-Tyrosine Kinases, RC31-1245, synthetic lethality, respiratory tract diseases, [SDV] Life Sciences [q-bio], Drug Resistance, Neoplasm, metabolic addiction, Cancer research, Imatinib Mesylate, Neoplastic Stem Cells, Original Article, metabolic stress, Stem cell, Asparagine, Tyrosine kinase
وصف الملف: application/pdf; Print-Electronic; application/octet-stream
-
2
المؤلفون: Blatt, K, Menzl, I, Eisenwort, G, Cerny-Reiterer, S, Herrmann, H, Herndlhofer, S, Stefanzl, G, Sadovnik, I, Berger, D, Keller, A, Hauswirth, A, Hoermann, G, Willmann, M, Rülicke, T, Sill, H, Sperr, WR, Mannhalter, C, Melo, JV, Jäger, U, Sexl, V, Valent, P
المساهمون: Imperial College Trust
المصدر: Neoplasia: An International Journal for Oncology Research, Vol 20, Iss 6, Pp 632-642 (2018)
Neoplasia (New York, N.Y.)مصطلحات موضوعية: Original article, GO, gemtuzumab-ozogamicin, NSG, NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ, Antigens, CD34, PB, peripheral blood, TKI, tyrosine kinase inhibitor, lcsh:RC254-282, Cell Line, OS, overall survival, Mice, LSC, leukemic stem cell, CML, chronic myeloid leukemia, Mice, Inbred NOD, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, hemic and lymphatic diseases, Biomarkers, Tumor, Animals, Humans, Oncology & Carcinogenesis, Ph, Philadelphia chromosome, Gene Expression Regulation, Leukemic, Stem Cells, 1103 Clinical Sciences, MNC, mononuclear cell, ALL, acute lymphoblastic leukemia, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, ADP-ribosyl Cyclase 1, Leukemia, Myeloid, Acute, BM, bone marrow, Neoplastic Stem Cells, Female, SCT, stem cell transplantation
-
3
المؤلفون: Letizia Foroni, Jane F. Apperley, Mary Alikian, Robert Peter Gale
المصدر: Biomolecular Detection and Quantification, Vol 11, Iss C, Pp 4-20 (2017)
Biomolecular Detection and Quantificationمصطلحات موضوعية: Oncology, Pathology, SCT, stem cell transplant, Review Article, Disease, Biochemistry, lcsh:Microbiology, CMR, complete molecular response/remission, ZMW, zero-mode wave-guided, 0302 clinical medicine, LSC, leukemic stem cell, EURO-SKI, European Stop Tyrosine Kinase Inhibitor Study, DESTINY, De-Escalation and Stopping Treatment of Imatinib, Nilotinib or sprYcel in Chronic Myeloid Leukaemia, NTC, No Template Control, PCR, Polymerase Chain Reaction, lcsh:QH301-705.5, ABL, RT, reverse transcription, CP, chronic phase, ALL, acute lymphoblastic leukaemia, CAP, College of American Pathology, KDa, Kilo Dalton, AP, accelerated phase, μg, microgram, RT-dPCR, reverse transcription-digital polymerase chain reaction, 030220 oncology & carcinogenesis, NGS, TKD, tyrosine kinase domain, ARQ, armored RNA Quant, IRIS, interferon and cytarabine versus STI571, medicine.medical_specialty, Cancer therapy, IS, International Scale, cDNA, coding or complimentary DNA, RT-qPCR, reverse transcription-quantitative polymerase chain reaction, Chronic myeloid leukaemia, 03 medical and health sciences, ELN, European Leukaemia Net, STIM, stop imatinib, Molecular Biology, CML, chronic myeloid leukaemia, LPC, leukemic progenitor cells, NGS, next generation sequencing, BMT, bone marrow transplantation, Q-PCR, quantitative polymerase chain reaction, respiratory tract diseases, IC, inhibotory concentration, MMR, major molecular response/remission, SMRT, single-molecule real-time sequencing, Mbp, mega base pair, dPCR, digital polymerase chain reaction, m-bcr, minor-breakpoint cluster region, dMIQE, Minimum Information for Publication of Quantitative Digital PCR Experiments, PFS, Progression Free Survival, lcsh:QR1-502, GUSB, glucuronidase beta gene, Kbp, Kilo Base Pairs, μ-bcr, micro-breakpoint cluster region, ABL1, Abelson murine leukaemia virus, MRD, minimal residual disease, TKI, tyrosine kinase inhibitor, DNA, deoxyribonucleic acid, Structural Biology, hemic and lymphatic diseases, CES, capillary electrophoresis sequencing, CML, μl, microliter, breakpoint cluster region, Myeloid leukemia, allo-SCT, Allogeneic Stem Cell Transplantation, LoQ, limit of quantification, mRNA, messenger RNA, medicine.anatomical_structure, MRD, emPCR, emulsion PCR, Molecular Medicine, Ph, Philadelpia, WHO, World Health Organisation, ATP, adenosine triphosphate, Bp, base pair, NCCN, National Comprehensive Cancer Network, QC, Quality Control, BC, blast crisis, LoD, limit of detection, PB, Peripheral Blood, gDNA, genomic deoxyribonucleic acid, Internal medicine, InDels, insertions and deletions, Molecular monitoring, medicine, EAC, Europe Against Cancer, nM, manomolar, business.industry, dPCR, MR, deep molecular response/remission, M-bcr, major-breakpoint cluster region, Gold standard (test), lcsh:Biology (General), NEQAS, National External Quality Assessement Service, BM, bone marrow, BCR, breakpoint cluster region, Bone marrow, business, 030215 immunology
-
4دورية أكاديمية
المؤلفون: Alikian M; Centre for Haematology, Department of Medicine, Imperial College London Hammersmith Hospital, London UK; Imperial Molecular Pathology, Imperial College Healthcare Trust, Hammersmith Hospital, London, UK., Gale RP; Centre for Haematology, Department of Medicine, Imperial College London Hammersmith Hospital, London UK., Apperley JF; Centre for Haematology, Department of Medicine, Imperial College London Hammersmith Hospital, London UK., Foroni L; Centre for Haematology, Department of Medicine, Imperial College London Hammersmith Hospital, London UK.
المصدر: Biomolecular detection and quantification [Biomol Detect Quantif] 2017 Feb 14; Vol. 11, pp. 4-20. Date of Electronic Publication: 2017 Feb 14 (Print Publication: 2017).
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Elsevier GmbH Country of Publication: Germany NLM ID: 101667177 Publication Model: eCollection Cited Medium: Print ISSN: 2214-7535 (Print) Linking ISSN: 22147535 NLM ISO Abbreviation: Biomol Detect Quantif Subsets: PubMed not MEDLINE
Full Text via ClinicalKey 
Full Text Finder